Article

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients

2022-07-11

Abstract excerpt

<h4>Background: </h4> Lung Squamous Cell Carcinoma (LUSC) is an aggressive malignancy with limited therapeutic options. The response to immune therapy is a determining factor for the prognosis of LUSC patients. This study aimed to develop a reliable immune-related prognostic signature in LUSC. <h4>Methods: </h4>. We extracted gene expression and clinical data of LUSC from The Cancer Genome Atlas (TCGA). A total of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 828afa3f-d62c-52fc-af4a-93985b2ad707
DOI: 10.21203/rs.3.rs-1595353/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsDOI 10.21203/rs.3.rs-1595353/v2Read

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma PrognosisSemantic proximity Read

Development of an anoikis-related gene signature for lung squamous cell carcinoma to predict prognosis, immune landscape, and immunotherapy responseSemantic proximity Read

Validation of an Immune-Related Gene Pair Index as a Prognostic Marker of Lung Squamous Cell CarcinomaSemantic proximity Read

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.Semantic proximity Read

The tumor environment immune phenotype of LUSC by genome-wide analysisSemantic proximity Read

The tumor environment immune phenotype of LUSC by genome-wide analysis.Semantic proximity Read

A Four-gene Autophagy-related Prognostic Signature and Its Association With Immune Landscape in Lung Squamous Cell CarcinomaSemantic proximity Read

The construction and validation of integrated immune and metabolic gene signatures for clinical prognostic model of lung squamous cell carcinomaSemantic proximity Read

A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinomaSemantic proximity Read

Development and validation of an individualized immune prognostic model in stage I-III lung squamous cell carcinoma.Semantic proximity Read

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read